|
⚲
|
| Keyboard |
| Coughlin Timothy
✚
|
|
|---|---|
| CIK # | 0001376043 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001376043] | |
| 4 | [0001376043] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Coughlin Timothy | |
| Travere Therapeutics Inc | |
| Vir Biotechnology Inc | |
| ADC Therapeutics SA | |
| aTYR Pharma Inc | |
| Fate Therapeutics Inc | |
| Neurocrine Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Travere Therapeutics Inc TVTX
Common Stock
|
2025-10-31 | Sell | 18,000 | $35.03 | 630,540 |
|
Travere Therapeutics Inc TVTX
Common Stock
|
2025-10-31 | Option exercise | 10,000 | $17.44 | 174,400 |
|
Travere Therapeutics Inc TVTX
Common Stock
|
2025-10-31 | Option exercise | 8,000 | $16.33 | 130,640 |
|
Travere Therapeutics Inc TVTX
Director stock option (right to buy) · derivative
|
2025-10-31 | Option exercise | 8,000 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Director stock option (right to buy) · derivative
|
2025-10-31 | Option exercise | 10,000 | $0.00 | |
|
ADC Therapeutics SA ADCT
Common Shares
|
2025-06-03 | Grant | 40,000 | $0.00 | |
|
ADC Therapeutics SA ADCT
Stock Options (Right to Buy) · derivative
|
2025-06-03 | Grant | 80,000 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Stock option (right to buy) · derivative
|
2025-05-15 | Grant | 19,500 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Common Stock
|
2025-05-15 | Grant | 6,500 | $0.00 | |
|
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
|
2025-05-01 | Grant | 50,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2024-06-07 | Grant | 40,000 | $0.00 | |
|
aTYR Pharma Inc LIFE
Common Stock
|
2024-05-30 | Buy | 50,000 | $1.75 | 87,500 |
|
aTYR Pharma Inc LIFE
Stock Option (right to buy) · derivative
|
2024-05-22 | Grant | 24,000 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Stock option (right to buy) · derivative
|
2024-05-08 | Grant | 19,500 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Common Stock
|
2024-05-08 | Grant | 6,500 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2023-06-06 | Grant | 40,000 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Stock option (right to buy) · derivative
|
2023-05-17 | Grant | 13,500 | $0.00 | |
|
aTYR Pharma Inc LIFE
Common Stock
|
2023-05-17 | Gift | 6,000 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Common Stock
|
2023-05-17 | Grant | 4,500 | $0.00 | |
|
aTYR Pharma Inc LIFE
Common Stock
|
2023-05-17 | Gift | 6,000 | $0.00 | |
| showing 20 of 126 most recent transactions | |||||